Log in

NASDAQ:APYX - Apyx Medical Stock Price, Forecast & News

-0.19 (-2.37 %)
(As of 01/28/2020 05:38 AM ET)
Today's Range
Now: $7.82
50-Day Range
MA: $8.09
52-Week Range
Now: $7.82
Volume52,900 shs
Average Volume79,289 shs
Market Capitalization$267.21 million
P/E RatioN/A
Dividend YieldN/A
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:APYX



Sales & Book Value

Annual Sales$16.69 million
Book Value$2.64 per share


Net Income$64.01 million


Market Cap$267.21 million
Next Earnings Date3/11/2020 (Estimated)

Receive APYX News and Ratings via Email

Sign-up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.

Apyx Medical (NASDAQ:APYX) Frequently Asked Questions

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

How were Apyx Medical's earnings last quarter?

Apyx Medical Corp (NASDAQ:APYX) released its quarterly earnings data on Monday, November, 11th. The company reported ($0.13) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.18) by $0.05. The firm had revenue of $7.58 million for the quarter, compared to the consensus estimate of $6.78 million. Apyx Medical had a negative net margin of 66.77% and a negative return on equity of 20.25%. The firm's quarterly revenue was up 106.3% on a year-over-year basis. View Apyx Medical's Earnings History.

When is Apyx Medical's next earnings date?

Apyx Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Apyx Medical.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical updated its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $27.9-28.1 million, compared to the consensus revenue estimate of $27.67 million.

What price target have analysts set for APYX?

3 equities research analysts have issued 12-month target prices for Apyx Medical's shares. Their forecasts range from $8.00 to $10.00. On average, they expect Apyx Medical's share price to reach $9.00 in the next year. This suggests a possible upside of 15.1% from the stock's current price. View Analyst Price Targets for Apyx Medical.

What is the consensus analysts' recommendation for Apyx Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Apyx Medical.

Has Apyx Medical been receiving favorable news coverage?

Media headlines about APYX stock have been trending somewhat negative on Tuesday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Apyx Medical earned a news impact score of -1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Apyx Medical.

Who are some of Apyx Medical's key competitors?

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), Procter & Gamble (PG), Wells Fargo & Co (WFC), AT&T (T), Amgen (AMGN), Corbus Pharmaceuticals (CRBP), Kraft Heinz (KHC), Walgreens Boots Alliance (WBA) and Alibaba Group (BABA).

Who are Apyx Medical's key executives?

Apyx Medical's management team includes the folowing people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 53)
  • Ms. Tara H. Semb, CFO, Treasurer & Sec. (Age 49)
  • Mr. Moshe Citronowicz, Sr. VP (Age 66)
  • Mr. Todd Hornsby, Exec. VP (Age 43)

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Taylor Frigon Capital Management LLC (1.23%), Calamos Advisors LLC (0.40%), California Public Employees Retirement System (0.19%), Creative Financial Designs Inc. ADV (0.13%) and Astoria Strategic Wealth Inc. (0.03%).

Which institutional investors are selling Apyx Medical stock?

APYX stock was sold by a variety of institutional investors in the last quarter, including Taylor Frigon Capital Management LLC and Creative Financial Designs Inc. ADV.

Which institutional investors are buying Apyx Medical stock?

APYX stock was purchased by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, California Public Employees Retirement System and Astoria Strategic Wealth Inc..

How do I buy shares of Apyx Medical?

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $7.82.

How big of a company is Apyx Medical?

Apyx Medical has a market capitalization of $267.21 million and generates $16.69 million in revenue each year. The company earns $64.01 million in net income (profit) each year or ($0.29) on an earnings per share basis. Apyx Medical employs 222 workers across the globe.View Additional Information About Apyx Medical.

What is Apyx Medical's official website?

The official website for Apyx Medical is http://www.apyxmedical.com/.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]

MarketBeat Community Rating for Apyx Medical (NASDAQ APYX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about Apyx Medical and other stocks. Vote "Outperform" if you believe APYX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APYX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: S&P 500 Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel